PHX — Pharmx Technologies Balance Sheet
0.000.00%
- AU$42.86m
- AU$40.83m
- AU$7.74m
Annual balance sheet for Pharmx Technologies, fiscal year end - June 30th, AUD millions except per share, conversion factor applied.
2022 June 30th | 2023 June 30th | 2024 June 30th | 2025 June 30th | 2026 June 30th | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Cash | |||||
| Cash and Equivalents | |||||
| Cash and Short Term Investments | 5.76 | 12.8 | 13.1 | 4.17 | 2.57 |
| Net Total Accounts Receivable | |||||
| Net Total Receivables | 2.63 | 2.6 | 3.15 | 1.49 | 2.8 |
| Total Inventory | |||||
| Total Other Current Assets | |||||
| Total Current Assets | 8.59 | 22.6 | 16.4 | 5.76 | 7.5 |
| Gross Property, Plant And Equipment | |||||
| Accumulated Depreciation | |||||
| Net Property, Plant And Equipment | 0.603 | 0.047 | 0.243 | 0.806 | 0.545 |
| Net Goodwill | |||||
| Net Intangible Assets | |||||
| Other Long Term Assets | |||||
| Total Assets | 30.8 | 36.5 | 29.9 | 18.8 | 27.3 |
| Accounts Payable | |||||
| Payable / Accrued | |||||
| Notes Payable / Short Term Debt | |||||
| Current Portion of Long Term Debt / Capital Leases | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 5.11 | 12.3 | 11.9 | 1.73 | 3.22 |
| Capital Lease Obligations | |||||
| Total Long Term Debt | |||||
| Total Debt | |||||
| Deferred Income Tax | |||||
| Total Other Liabilities | |||||
| Total Liabilities | 7.57 | 14.3 | 13.9 | 2.9 | 3.99 |
| Common Stock | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Total Equity | 23.2 | 22.2 | 16 | 15.9 | 23.3 |
| Total Liabilities & Shareholders' Equity | 30.8 | 36.5 | 29.9 | 18.8 | 27.3 |
| Total Common Shares Outstanding |